⌘K
Loading ticker…
As of 2026-08-24, Pliant Therapeutics, Inc. Common Stock (PLRX) has a 3-month relative strength percentile of 36 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 44. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.8%, relative volume 0.74×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
PLRX appears in 1 ETF as of May 2026: VHT at 0.00% weight, $193K notional.
Held by 5 ETFs · $3M across latest filings · largest weight 0.02% (IWC).
Top 1 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.00% | $193K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PLRX Jan avg: 15.26% median: -0.93% win: 25% σ: 44.77% n: 4 2022-04-12 → 2026-07-31 | PLRX Feb avg: -20.27% median: -10.26% win: 25% σ: 32.91% n: 4 2022-04-12 → 2026-07-31 | PLRX Mar avg: -21.61% median: -11.31% win: 0% σ: 26.72% n: 4 2022-04-12 → 2026-07-31 | PLRX Apr avg: -3.58% median: -3.17% win: 40% σ: 16.23% n: 5 2022-04-12 → 2026-07-31 | PLRX May avg: -7.31% median: -3.92% win: 40% σ: 11.65% n: 5 2022-04-12 → 2026-07-31 | PLRX Jun avg: -1.79% median: -11.38% win: 20% σ: 24.76% n: 5 2022-04-12 → 2026-07-31 | PLRX Jul avg: 33.10% median: 25.86% win: 60% σ: 50.05% n: 5 2022-04-12 → 2026-07-31 | PLRX Aug avg: 2.70% median: 2.81% win: 50% σ: 10.38% n: 4 2022-04-12 → 2026-07-31 (current) | PLRX Sep avg: -3.58% median: -3.52% win: 50% σ: 11.04% n: 4 2022-04-12 → 2026-07-31 | PLRX Oct avg: 10.67% median: 16.28% win: 75% σ: 18.06% n: 4 2022-04-12 → 2026-07-31 | PLRX Nov avg: -9.38% median: -4.74% win: 0% σ: 11.24% n: 4 2022-04-12 → 2026-07-31 | PLRX Dec avg: 1.69% median: 0.30% win: 50% σ: 22.70% n: 4 2022-04-12 → 2026-07-31 |